Novartis Venture Fund

VC Massachusetts, United States ·Founded 1996

Overview

Looks for unmet need and clinical impact, novel proprietary science and understanding of mechanism, management and board experience and capital efficiency in the program.

Investment Focus

  • Innovative therapeutics and platforms addressing unmet patient needs
  • Early-stage life sciences companies
  • Global focus with emphasis on North America and Europe
  • Active collaboration with portfolio companies to deliver clinical impact
  • Companies developing novel therapeutics and platforms
  • Early to mid-stage life sciences companies
  • Global presence with a focus on North America and Europe
  • Active involvement in company boards
  • Alignment with Novartis' therapeutic areas including oncology, immunology, neuroscience, and cardiovascular medicine

Portfolio Companies

Molecular PartnersAlnylam PharmaceuticalsChinook TherapeuticsAdimabArctos MedicalCadent TherapeuticsGyroscope TherapeuticsKymabMorphoSys AGRegulus TherapeuticsTornado TherapeuticsBorealis BiosciencesVersant VenturesAveXisBioNano GenomicsHealth Ever BiotechKisoJi

Reach Novartis Venture Fund directly

Verified work email, phone and LinkedIn for the full team — one spreadsheet, one payment, yours to keep.

Unlock full contacts →

Frequently asked questions about Novartis Venture Fund

What sectors does Novartis Venture Fund invest in?

Novartis Venture Fund invests in Healthcare, Life Sciences, Healthcare Services, Digital Health, Pharmaceuticals and Medical Devices, and is based in Massachusetts, United States. Novartis Venture Fund is listed as a vc in the ConnectSafely investor database.

What stage does Novartis Venture Fund invest at?

Novartis Venture Fund backs companies at Seed, Series A, Series B, Growth, Late Stage and Pre-IPO, writing cheques of 5M - 25M.

Which regions does Novartis Venture Fund invest in?

Novartis Venture Fund invests across United States, United Kingdom, Canada, Germany, Japan and China.

What companies has Novartis Venture Fund invested in?

Novartis Venture Fund's portfolio includes Molecular Partners, Alnylam Pharmaceuticals, Chinook Therapeutics, Adimab, Arctos Medical, Cadent Therapeutics, Gyroscope Therapeutics and Kymab.

How do I contact Novartis Venture Fund?

Novartis Venture Fund's contact details — including phone and LinkedIn — are listed in the ConnectSafely investor database, along with its website and the LinkedIn profiles of the team.

Last updated · Source: ConnectSafely investor database